Skip to main content
. Author manuscript; available in PMC: 2020 Jul 30.
Published in final edited form as: N Engl J Med. 2020 Jan 30;382(5):485–486. doi: 10.1056/NEJMc1910508

Table 1.

Subgroup Analysis According to Type of Lower Respiratory Tract Infection.*

Subgroup 90-Day Mortality 1-Year Mortality
Procalcitonin Usual Care Difference (95% CI) Procalcitonin Usual Care Difference (95% CI)
no./total no. (%) percentage points no./total no. (%) percentage points
CAP 10/167 (6.0) 8/161 (5.0) 1.0 (−51.2 to 53.2) 18/167 (10.8) 21/161 (13.0) −2.3 (−64.6 to 60.0)
COPD 13/265 (4.9) 5/259 (1.9) 3.0 (−38.0 to 43.9) 25/265 (9.4) 26/259 (10.0) −0.6 (−53.7 to 52.4)
Asthma 2/310 (0.6) 2/336 (0.6) 0.0 (−25.9 to 26.0) 8/310 (2.6) 9/336 (2.7) −0.1 (−37.1 to 36.9)
Acute bronchitis 3/208 (1.4) 1/190 (0.5) 0.9 (−31.3 to 33.1) 3/208 (1.4) 5/190 (2.6) −1.2 (−40.3 to 37.9)
*

Percentages are Kaplan–Meier estimates. A patient could have more than one final diagnosis. Data are from National Death Index query results received in December 2018. CAP denotes community-acquired pneumonia, and COPD chronic obstructive pulmonary disease.